|Year : 2012 | Volume
| Issue : 2 | Page : 133-138
Cloning, sequencing, and in silico characterization of Omp 28 of Salmonella Typhi (strain MTCC 733) to develop r-DNA vaccine for typhoid fever
Anjani Saxena, Shantanu Tamuly, MK Saxena
Animal Biotechnology Center, Department of Veterinary Physiology and Biochemistry, G.B.P.U.A and T, Pantnagar, Uttarakhand, India
|Date of Web Publication||3-Oct-2012|
M K Saxena
Animal Biotechnology Center, Department of Veterinary Physiology and Biochemistry, G.B. Pant University of Agriculture and Technology, Pantnagar 263145, Uttarakhand
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Typhoid is one of the most important diseases of human beings caused by Salmonella Typhi. There are many vaccine reported against Salmonella Typhi, but search for new candidate vaccine antigens is still going on because presently available vaccines have several limitations such as short-term immunity, high cost, and allergic reaction. Several approaches such as subunit vaccines, Vi polysaccharide, mutant vaccines, and r-DNA vaccines have been tested. r- DNA vaccines have shown some promising potential (targeted Omp). Omp 28 had shown very promising results and suggests that it should be used in further studies of animal protection against the disease. Objective: Cloning, Sequencing and In silico analysis of Omp 28 gene to develop r-DNA vaccine of S.Typhi. Materials and Methods: Omp 28 is made up of three identical subunits of 9.6 kDa showing PCR amplicon of 330 bp which has been cloned in the pJET vector. Recombinant clones has been sequenced, and data submitted to NCBI. Secondary structure was deduced by the Chou Fasman and Garnier method. The sequence of Omp 28 was studied for antigenic indexing, epitope mapping, and MHC mapping using various bioinformatics tool. Results and Conclusion: The sequence of Omp 28 has been assigned accession no GQ 907044.1 by NCBI. Secondary structure has shown it has more alpha region. Hydrophobic plot and surface probability plot shows most amino acids are surface exposed which is a requirement to develop a r-DNA vaccine. Antigenic sites are located within surface exposed regions and eight antigenic determinants are present in Omp 28. On Prosite analysis of Protein shown two motifs i.e. anaphylatoxin domain signature motif at position 219-252 and other one was iron sulphur binding region signature motif at position 36-44. On epitope analysis total six major B cell epitopes were observed which can provoke humoral immunity .On T cell epitope mapping several major epitopes has been found in case of MHC class I and MHC class II. It indicates that Omp 28 can provoke cell mediated as well as humoral immunity and can be proven a promising candidates of Salmonella Typhi.
Keywords: Outer membrane protein, r-DNA vaccine, Salmonella Typhi
|How to cite this article:|
Saxena A, Tamuly S, Saxena M K. Cloning, sequencing, and in silico characterization of Omp 28 of Salmonella Typhi (strain MTCC 733) to develop r-DNA vaccine for typhoid fever. J Nat Sc Biol Med 2012;3:133-8
|How to cite this URL:|
Saxena A, Tamuly S, Saxena M K. Cloning, sequencing, and in silico characterization of Omp 28 of Salmonella Typhi (strain MTCC 733) to develop r-DNA vaccine for typhoid fever. J Nat Sc Biol Med [serial online] 2012 [cited 2020 Nov 24];3:133-8. Available from: http://www.jnsbm.org/text.asp?2012/3/2/133/101885
| Introduction|| |
Typhoid is one of the most important diseases caused by Salmonella More Detailse worldwide and it causes 60,0000 deaths per annum.  As per the WHO report the total cost associated with Salmonella is estimated at US$ 3 billion annually in the United States.  At present detail about the epidemiological or incidence rate of typhoid for any state is not available in India though there are numerous reports available which indicate that the typhoid is of great concern to India. , The emergence of multidrug-resistant Salmonella typhi ncreased virulence and high physiological adaptability has further complicated the disease management. , Vaccination plays an important role in preventing the disease. Presently, three approaches has been used for development of vaccine against typhoid these are i.e. whole cell typhoid vaccine,  Vi polysaccharide vaccine  and oral typhoid vaccine.  Whole cell typhoid vaccine prepared by inactivating virulent microorganism is safe and cheap, but causes local pain, inflammation and fever and it is not commonly used. Vi capsular polysaccharide vaccine of S. Typhi was developed from the wild type S.Typhi strain.  It is not economical. Attenuated live bacterial vaccine (LBV) is an attenuated mutant strain of S. Typhi. One of its drawbacks is the requirement for multiple doses for optimal immunogenicity. Therefore, there is a need of a better vaccine. Outer membrane protein (Omps) has been tested extensively and has shown good potential as vaccine candidate. Omps interface the cell with the environment, has important virulent factors and played a significant role in the pathobiology of gram-negative bacteria and bacterial adaptation.  Over the past years, several Salmonella Omps have been investigated as potential vaccine candidates and diagnostic antigens.  The molecular structure and function of Omps and their respective genes , have been studied. However, only a small number of Omps have so far been characterized.  Study of other gram-negative bacteria demonstrated that porins represent the most abundant class of Omps that are protective and show some degree of antigenic heterogeneity among different strains.  Porins play a key role in the uptake and disposal of small hydrophilic compounds and a potential role as immunogens in diagnostic assays and vaccination.  Outer membrane proteins of Salmonella Typhi are immunogenic and among them Omp28 had shown very promising results. Antibodies against Omp28 were detected by ELISA in 43% of sera from typhoid fever convalescent patients or antisera from mice immunized with Omp 28 gave a positive bactericidal test killing 50% of S. Typhi cells in serum dilution of 1/80 and 1/320.  Complete amino acid sequence and location of Omp 28 of S.Typhi has also been analysed.  As it is difficult to isolate Omp(s) in bulk for vaccine purpose, this study was undertaken to clone and sequence and in silico analysis of Omp 28 gene of S.Typhi to further explore the possibility of r-DNA vaccine of S.Typhi.
| Materials and Methods|| |
Culture of Salmonella Typhi (MTCC 733) was obtained from Institute of Microbial Technology, Chandigarh and was maintained in Growth Medium 3. Escherichia More Details coli DH5α used in the cloning experiments was purchased from Bangalore Genei and grown in Luria broth (LB). The culture of Salmonella was revived on Luria Bertani broth (Hi Media, India) and Luria Bertani agar and the purity of the culture was tested using colony character on Brilliant Green Agar (Hi media, India). Single colony was inoculated in LB broth and tested by Salmonella specific PCR  and biochemical tests.
Cloning of Omp 28 gene
Genomic DNA of Salmonella Typhi was isolated by the C-TAB method.  For amplification of Omp28 gene following primers were used which were designed using the complete amino acid sequence reported earlier. 
Primer 1: ATG AAT AAA TTC TCC CTT GC
Primer 2: TTA TTT TGA GAG TTC TTT CTT GA
Twenty-five microliters of the PCR reaction mixture containing 40 ng of genomic DNA, 20 pmole of each primer, 200 μM of each dNTPs, 1.5 mM MgCl 2 , 2U of jumpstart polymerase (Sigma, USA) were amplified by PCR and were under standard conditions in a thermal cycle with the following programme, i.e. initial denaturation at 94° C for 5 min followed by 30 cycles of denaturation at 94°C for 1 min annealing at 46°C for 1 min, 68°C for 1 min and the final elongation was carried out at 68°C for 5 min. The amplified product was loaded on 1.5% agarose gel and eluted from gel using a QIA quick gel extraction kit (Qiagen, USA). After blunting the amplified product, it was cloned into the pJET cloning vector (Qiagen, Germany). Clones were inoculated in LB ampicillin tubes and the plasmid was isolated by the alkaline lysis method and an insert from plasmid was released by digestion with Xba I and Not I restriction enzymes. The recombinant clones were screened to obtain insert of desired size verified by colony PCR amplification. The cloned product was sequenced by Ocimum Biosolutions Ltd., Hyderabad. The sequence was submitted to NCBI and assigned the accession no. GQ 907044.
Sequence similarity and phylogenetic analysis
The sequence was subjected to homology search using BLASTn. , The sequence showing maximum similarity with Omp28 was subjected to multiple sequence alignment by CLUSTALW  and a phylogenetic tree was constructed based on the protein sequence using the UPGMA method (DNASTAR, USA).
Protein structural and functional analysis
The Omp28 gene sequence was translated to the protein sequence using the translation tool (http://ca.expasy.org/tool). Translated Omp protein was subjected to protein domain functional analysis using Pfam version 23.0,  Prosite version 20.37,  Psort tools, and SWISS-PROT model analysis.  In silico translation and analysis of primary structure of outer membrane protein were performed using online bioinformatics tools.  On the basis of primary structure, physiochemical properties of Omp28 protein were also deduced using the same software. Protein secondary structure and antigenic analysis were also performed by PROTEAN , Program (DNASTAR, USA).Protein 3D structure has been made by submitting translated sequence of Omp 28 gene sequence in Bhagirath online server.
B-cell and T-cell epitope prediction
To find out the B-cell epitope regions of Omp 28 protein, the Bepripred prediction tool of IEDB analysis resources was used. A critical step in developing immune response against pathogens is the recognition of antigenic peptides presented by MHC Class I and II molecules.  Peptides are divided into binders and nonbinders and binding affinities of MHC Class I and II are calculated by epitope database analysis.
| Results and Discussion|| |
Purity of culture was confirmed by biochemical characterization and Salmonella-specific PCR. In biochemical characterization culture was MR+, VP-, Urease- which was identical to standard biochemical tests of Salmonella Typhi. In Salmonella-specific PCR, an amplicon of 496 bp was obtained which corresponds to the expected amplicon of Salmonella by this method. 
Cloning and sequencing of the Omp 28 gene
Omp 28 gene is made up of three identical subunits and the primer was designed corresponding to one subunit of protein. The PCR product of the corresponding size (330 bp) was obtained when the genomic DNA of Salmonella Typhi was amplified with these primers [Figure 1]a. The amplified products were separately cloned into the clone JET cloning vector (Fermentas, USA) and transformed into DH5α competent cells. Recombinant clones have been selected by colony PCR [Figure 1]b. The restriction digestion of each of the recombinant clones with Xba I and Not I enzymes confirmed the presence of an approximately 330 bp sequence within the recombinant plasmid for Omp 28 gene [Figure 1]c.
|Figure 1: (a) Specific Omp 28 gene PCR of S.Typhi MTCC 733, Lane 1: Omp 28 gene PCR on S.Typhi MTCC 733, Lane M: Low range DNA ruler Plus(Genei), (B) Colony PCR for screening of recombinant clones, Lane 1: Negative Control, Lane 2: Positive Control, Lane 3-7: PCR amplicon of Clones, Lane M: Low range DNA ruler Plus(Genei), (C) Restriction Enzyme Digestion with Not I and Xba I to release insert, Lane 1: Positive amplicon of selected clone, Lane M: Low range DNA ruler plus(Gene), Lane 2: Digested Plasmid with Not I and Xba I to release insert|
Click here to view
Nucleotide sequence accession number
The sequence of the cloned insert has been submitted to NCBI, Genbank data and has assigned an accession no GQ 907044.1. The length of this gene is 330 bp and GC content of 40-45%.
Sequence analysis of Omp 28 gene
The nucleotide sequence of Omp 28 revealed a putative open reading frame beginning with an ATG initiation codon which remained open to the end of the sequence obtained. The 330 bp functional Omp was found to be 325 bp in length having the GC content of 40-45%. The Omp 28 gene of Salmonella Typhi shows maximum homology with Salmonella enterica serovars Typhimurium, Paratyphi, and Enteritidis by NCBI BLAST search. The Omp 28 gene of Salmonella Typhi shows maximum homology with Salmonella enterica serovars Typhimurium, Paratyphi, and Enteritidis by NCBI BLAST search. The Omp 28 gene of Indian isolates of S. Typhi serotypes was aligned for homology with the reported sequence of S. Typhi strains MDR 9, Omp C, Omp F, and AG3 different strains, and the percentage of identity and divergence among 15 strains of S. Typhi has been depicted in [Figure 2]. The result of phylogenetic tree analysis showed a close relationship between Indian isolate of S. Typhi Omp 28 gene to S. Typhi Omp C and Omp F gene of S. Typhi.
Analysis of amino acid sequence and secondary structure predictions
|Figure 2: Phylogenetic Tree made of omp 28 gene with different serovars of S.Typhi|
Click here to view
The deduced sequences of Omp 28 gene of S. Typhi contain 16 acidic charged amino acids and 11 are basic in nature. From them, 30 amino acids are charged and 31 are polar in nature. When the amino acids sequences were compared, it was observed that histidine was missing in the total amino acid sequence and there are two cysteine and three methionine amino acids are present. PI value of Omp 28 was found to be 4.53. The C-terminal of Omp 28 gene has characteristic amino acids as reported, but the terminal amino acid was lysine in place of phenylalanine which have been found more common in outer membrane protein. The presence of lysine in place of phenylalanine may be responsible for localization of Omp 28 in periplasm. The physiochemical analysis of Omp 28 using PROTEAN software showed a typical properties of containing a signal peptide [Figure 3]. Psorb analysis of Omp 28 gene also indicates its location in periplasm same as reported earlier.  In secondary structure analysis three membrane spanning α- helices were deduced [Figure 4].
|Figure 3: Hydropholicity, Surface Probability Plot and Antigenic Index of translated sequence of Omp 28 gene, (a) Hydrophobic Plot, (b) Surface probability plot, (c) Antigenic determination|
Click here to view
|Figure 4: Determination of Secondary structure of translated sequence of Omp 28 gene|
Click here to view
Antigenic characterization and Motif analysis of Omp 28 gene
Antigenic characterization of the protein was done with PROTEAN.  Several hydrophilic peaks which represent surface exposed domains were present in Omp 28. These variable domains may represent unique epitopes. The surface probability plot indicates that most of the amino acids are surface exposed. The antigenic index creates a linear surface contour profile of the protein. Antigenic sites are located within a surface exposed region of a protein and the PROTEAN programme offers a mean for predicting potential antigenic determinants. Hydrophilic domains corresponding to the cell surface exposed domains were highly variable in their amino acid composition [Figure 3]a. There are so many domains present which are surface exposed and it is a requirement for development of vaccine.[Figure 3]b. Eight antigenic determinants or epitopes were found in Omp 28 protein with protean software  [Figure 3]c.The overall structure of Omp 28 is conserved; however, there were small variable regions in the proteins of each serotypes which may work as strain-specific epitopes.
Prosite analysis showed the presence of two motifs in Omp 28, i.e. the anaphylatoxin domain signature motif at position 219-252 other one was the iron sulfur binding region signature motif at position 36-44 [Table 1]. On Pfam analysis no similar protein could be identified in the database. Omp 28 gene was submitted for Swiss-Prot model analysis, but this gene does not match with available models in the Web site. Translated Omp 28 gene sequence has been submitted to Bhagirath online server and 3 D Structure has been obtained [Figure 5].
|Figure 5: 3 D Structure of translated sequence of Omp 28 gene of S.Typhi|
Click here to view
|Table 1: Motif analysis of translated sequence of Omp 28 gene of S.Typhi|
Click here to view
B-cell and T-cell epitope mapping
To find out the B-cell epitope regions of Omp protein, the Bepripred prediction tool of IEDB analysis resources was used. The sequence was loaded into the tool window and searched for most potential linear epitopes [Figure 6]. A total of six B-cell epitopes were analyzed [Table 2]. Among these six epitopes, mainly three were found to be more immunogenic as predicted by the scores of epitope. A peptide length of 5 or more amino acids are supposed to be good B-cell epitope. A critical step in developing immune response against pathogens is the recognition of antigenic peptides presented by MHC Class I and II molecules. Peptides are divided into binders and nonbinders, and binding affinities of MHC Class I and II are calculated by epitope database analysis and ranked according to their percentile. We have analysed our sequence for MHC Class I and II binding peptide epitope. For MHC Class II, a percentile rank for each of the four methods (ARB, Combinatatorial library SMM-align and Sturniolo) was generated by comparing the peptide score against the scores of five million 15 mers selected from SWISS-PROT database. A small percentile rank indicates high affinity. A graph was been plotted between percentile rank and amino acid position. There are different types of MHC class I alleles in the case of mouse, i.e. H 2 kk, H 2 kd, H 2 Ld. IEDB recommend that low percentile peptides are good binders. Omp 28 gene is having 16 major epitopes for H 2 kk, 14 epitopes for H 2 kd, and 10 epitopes for H 2 Ld for MHC Class I [Figure 7]a. There are three alleles for MHC Class II molecules for mouse, i.e., H 2 IAb, H 2 Ied, H 2 Iad. IEDB recommend that top percentile peptides are good binders for MHC Class II molecules. Translated sequence of Omp 28 gene is having 27 for H 2 Iab, 64 for H 2 Ied, and 23 epitopes for H 2 Iad which has been found in the case of MHC class II molecules [Figure 7]b. Recognition of a peptide bound to MHC molecules by a T-cell receptor is a critical stage, and it is done by H 2 Iab binding prediction. It has been analyzed through multiple sequence alignment tools that S. Typhi Omp 28 consists of eight variable regions on comparison with other porins with well known crystal structures. These variable regions have been found to be on the outer side of the membrane, and therefore, they have high probability to be presented for B-cell recognition and elicit immune response. These findings clearly depict that Omp 28 has recognized B-cell epitopes and as it shares maximum similarity with OmpC of S. Typhimurium (98%), these variable regions can be strongly predicted to act as possible B-cell epitopes capable of eliciting immune response. OmpC of Salmonella Typhi has also been purified using salt extraction procedures and its epitopes have been mapped. It is found to be a trimer made of 16 stranded β-barrel monomers and is a major cell surface antigen from the human pathogen Salmonella typhi. , Sequencing revealed that the C-terminus of Omp 28 has typical characteristic of Omps. The last residue at the C-terminus, phenylalanine has been reported to be highly conserved among outer membrane proteins and is essential for stability and correct assembly of protein into the outer membrane.  The 15 C-terminal amino acid residues of Omp 28 including the terminal phenylalanine were found to be hydrophobic in nature which is important for incorporation of the protein in the membrane. These results indicate the immunogenic importance of Omp 28 isolated from S. Typhi outer membrane and strongly suggest that it should be used in further studies of animal protection against the disease caused by this pathogenic bacterium.
|Figure 6: Major B cell epitopes of translated sequence of Omp 28 gene of S.Typhi|
Click here to view
|Figure 7a: MHC I epitopes identified through IEDB epitope prediction tool (a) MHC H-2-Kd allele, (b) MHC I H-2-kk allele first graph, (c) MHC I H-2-kk allele second graph, (d) MHC I, H-2-Ld graph |
Figure 7b: MHC II epitopes identified through IEDB epitope prediction tool, (a) MHC II H-2-Iab, (b) MHC II H-2-Ied allele first graph, (c) MHC II H-2-Ied allele Second graph, (d) H2-IAd Graph
Click here to view
|Table 2: Predicted B cell epitopes of translated sequence of Omp 28 gene|
Click here to view
| Acknowledgments|| |
The authors are thankful to Department of Science and Technology, Govt. of India, for financial support .The authors acknowledge Dean College of Veterinary and Animal Sciences and Director Experiment Station G. B. Pant University of Agriculture &technology for providing necessary facilities for this study.
| References|| |
|1.||Crump JA, Ram PK, Gupta SK, Miller MA,Mintz ED.Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries. Epidemiol Infect 2007;9:1-13. |
|2.||Report of WHO Consultation. Geneva Switzerland, 5-9 June 200 WHO/CDS/CSR/APH/2000. |
|3.||Chitinis V, Verma S, HemwaniN,Chitnis D. Multidrug resistant SalmonellaTyphi in India. Lancet 1999; 354:514-20. |
|4.||Mirza S, Kariuki S, Mamun KZ,Hart NJ. Analysis of plasmid and chromosomal DNA of multidrug resistant Salmonella enteric serovarTyphi from Asia. J Clin Microbiol 2000;38:1449-52. |
|5.||Walia M, Gaind R, Paul P, Mehta R, Agarwal P, Kalaivani M. Age related clinical and microbiological characteristics of enteric fever in India. Trans R Soc Trop Med Hyg 2006; 100:942-8. |
|6.||Shah MR, Ramamurthy T, Dutta P, Mitra U. Emergence of Salmonella typhi Vi antigen negative strains in an epidemic of multidrug resistant typhoid fever cases in Calcutta. Natl Med of India 2004; 13:164-70. |
|7.||Aschcroft MT, Singh B, Nicholson CC, Ritchie TM, Sorryane E, William F A. Seven year field trial of two typhoid vaccines in Guyana. Lancet 1967; 2:1056-9. |
|8.||Looney R J,Steigbiel RT. Role of the Vi antigen of Salmonella Typhi in resistance to host defense in vitro. J Lab Clin Med 1986; 108:506-16. |
|9.||Levine MM. Canneedle free administration of vaccine become the norm in global immunization. Natl Med 1976; 9:99-103. |
|10.||Jain HN, Jain SK. Characterization of an outer membrane protein of Salmonella enterica serovars Typhimurium that confers protection against typhoid. Clin Vaccine Immunol 2008; 15:1461-71. |
|11.||A. Isibasi, V. Ortiz, M. Vargas. Protection against Salmonella Typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella Typhi 9,12, d,Vi. Infect Immun 1988;56: 2953-9. |
|12.||Puente JL, Alvarez-Scherer V, Gosset G, Calva E. Comparative analysis of the Salmonella Typhi and Escherichia coli omp C gene. Gene 1989; 83:197-206. |
|13.||Puente JL, Verdugo-Rodríguez A, Calva E. Expression of Salmonella Typhi and Escherichia coli OmpC is influenced differently by medium osmolarity; dependence on Escherichia coli OmpR. Mol Microbiol 1991; 5:1205-10. |
|14.||Lin J, Huang S, Zhang QA. Outer membrane proteins: Key players for bacterial adaptation in host niches. Microbes Infect 2002; 4:325-31. |
|15.||Munson RS Jr, Shenep JL, Barenkamp SJ, Granoff DM Purification and comparison of outer membrane protein P2 from Haemophilusinfluenzae type b isolates. JClinInvestig1983;72:677-84. |
|16.||Benz R. Structure and function of porins from Gram-negative bacteria. Annu Rev Microbiol 1988;42 : 359-93. |
|17.||de Andrade CM, Ferreira AG, da Silva JD, Nascimento HJ, da Silva JG . Chemical and immunological characterization of a low molecular weight outer membrane protein of Salmonella Typhi. Microbiol Immunol 1998; 42: 521-6. |
|18.||Neves-Ferreira AG, de Andrade CM, Vannier-Santos MA, Perales J, Nascimento HJ, da Silva Junior JG. Complete amino acid sequence and location of Omp 28 an important immunogenic proteins from Salmonella enterica serovars Typhi. Protein J 2004; 23:71-7. |
|19.||Cohen ND, Neibergs HL, McGruder ED,Whitford HW, Behle RW, Ray PM, et al. Genus-specific detection of Salmonellae using the polymerase chain reaction (PCR).J Vet Diagn Investig 1993;5:368-371. |
|20.||Wilson K. Preparation of genomic DNA from bacteria. In: F.M. Ausabel, R.Brent, R.E. Kingston, D. D. Moore, J.G. Seidman, J.A. Smith and k. Struhl (ads). Current Protocols in Molecular Biology. unit, 2.4.1,(Wiley, New York) |
|21.||Altschul F, Gish ME, Myers M, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10. |
|22.||Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al.Gapped BLAST and Psi-BLAST: A new generation of protein database search programs. Nucleic Acid Res1997; 25:3389-402 |
|23.||Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence weighting, position specific gap penalities and weight matrix choice. Nucleic Acid Res 1994; 22:4673-80. |
|24.||Finn D, Mistry J and Schuster B. A. Pfam: Clans.web tools and services. Nucleic Acid Res.2006; 34:247-251. |
|25.||Castro ED, Sigrist CJ, Gattiker A, Bulliard V. Scan prosite: Detection of PROSITE signature matches and prorule associated functional and structural residues in proteins. Nucleic Acid Res 2006; 34:362-5. |
|26.||Gardy JL, Laird MR, Chen F. PSORT by 2.0 expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005; 5:617-23. |
|27.||Gasteiger E, Hoogland C, Gattiker A. Protein identification and analysis tools on the ExPASY server. In: John M, editor. The Proteomics protocols Handbook. 9th ed. New York: Humana Press; 2005.p. 571-607. |
|28.||Plaster TN. PROTEAN: Protein sequence analysis and prediction. Methods Mol Biol 1996;70:227-39. |
|29.||Jameson BA, Wolf H. The antigenic index: A novel algorithm for predicting antigenic determinants. Computer Applications in the Biosciences 1998; 4:181-6. |
|30.||Wang P, Sidney J, Courtney D, Bianca M, Sette A, Peters B. A systematic assessment of MHC Class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 2008; 4:1-23. |
|31.||Arockiasamy A, Krishnaswamy S. Prediction of B cell epitopes for Salmonella Typhi Omp C. J Biosci 1995; 20:235-43. |
|32.||Arockiasamy A, Murthy GS, Rukmini MR, Sundara Balaji N, Katpally UC, Krishnaswamy S. Conformational epitope mapping of Omp C, a major cell surface antigen from Salmonella typhi. J Struct Biol 2004; 148: 22-33. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]
[Table 1], [Table 2]